| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8973 |
| Human Intestinal Absorption | HIA+ | 0.9755 |
| Caco-2 Permeability | Caco2- | 0.6133 |
| P-glycoprotein Substrate | Non-substrate | 0.6539 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8994 |
| Non-inhibitor | 0.9397 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8636 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6738 |
| Metabolism |
| CYP450 2C9 Substrate | Substrate | 0.6723 |
| CYP450 2D6 Substrate | Non-substrate | 0.8845 |
| CYP450 3A4 Substrate | Non-substrate | 0.7545 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8944 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9045 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9464 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9040 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8562 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6846 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9046 |
| Non-inhibitor | 0.9154 |
| AMES Toxicity | Non AMES toxic | 0.9232 |
| Carcinogens | Non-carcinogens | 0.8713 |
| Fish Toxicity | High FHMT | 0.9857 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9229 |
| Honey Bee Toxicity | Low HBT | 0.7833 |
| Biodegradation | Not ready biodegradable | 0.9046 |
| Acute Oral Toxicity | III | 0.8090 |
| Carcinogenicity (Three-class) | Non-required | 0.6750 |